These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? Senni M; Adamo M; Metra M; Alfieri O; Vahanian A Eur J Heart Fail; 2019 Jul; 21(7):852-861. PubMed ID: 31116485 [TBL] [Abstract][Full Text] [Related]
4. Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After MitraClip Implantation: Results From the Mitra-FR Trial. Messika-Zeitoun D; Iung B; Armoiry X; Trochu JN; Donal E; Habib G; Brochet E; Thibault H; Piriou N; Cormier B; Tribouilloy C; Guerin P; Lefèvre T; Maucort-Boulch D; Vahanian A; Boutitie F; Obadia JF JACC Cardiovasc Imaging; 2021 Apr; 14(4):742-752. PubMed ID: 32950444 [TBL] [Abstract][Full Text] [Related]
5. One more option in heart failure: correction of mitral regurgitation with MitraClip Bini T; Agostini C; Stolcova M; Meucci F; Di Mario C Intern Emerg Med; 2019 Oct; 14(7):1033-1040. PubMed ID: 31297739 [TBL] [Abstract][Full Text] [Related]
6. MitraClip: How Do We Reconcile the Inconsistent Findings of MITRA-FR and COAPT? Mauricio R; Kumbhani DJ Curr Cardiol Rep; 2019 Nov; 21(12):150. PubMed ID: 31768771 [TBL] [Abstract][Full Text] [Related]
7. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Pibarot P; Delgado V; Bax JJ Eur Heart J Cardiovasc Imaging; 2019 Jun; 20(6):620-624. PubMed ID: 31115470 [TBL] [Abstract][Full Text] [Related]
10. Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip. Atianzar K; Zhang M; Newhart Z; Gafoor S Interv Cardiol; 2019 Feb; 14(1):45-47. PubMed ID: 30858892 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in patient selection and devices for transcatheter edge-to-edge mitral valve repair in heart failure. Orban M; Lüsebrink E; Braun D; Stocker TJ; Bagaev E; Hagl C; Näbauer M; Massberg S; Orban M; Hausleiter J Expert Rev Med Devices; 2020 Feb; 17(2):93-102. PubMed ID: 31923376 [No Abstract] [Full Text] [Related]
12. Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair. Koell B; Orban M; Weimann J; Kassar M; Karam N; Neuss M; Petrescu A; Iliadis C; Unterhuber M; Adamo M; Giannini C; Melica B; Ludwig S; Massberg S; Praz F; Pfister R; Thiele H; Stephan von Bardeleben R; Baldus S; Butter C; Lurz P; Windecker S; Metra M; Petronio AS; Hausleiter J; Lubos E; Kalbacher D; J Am Coll Cardiol; 2021 Dec; 78(24):2408-2421. PubMed ID: 34886961 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials. Anker SD; Friede T; von Bardeleben RS; Butler J; Khan MS; Diek M; Heinrich J; Geyer M; Placzek M; Ferrari R; Abraham WT; Alfieri O; Auricchio A; Bayes-Genis A; Cleland JGF; Filippatos G; Gustafsson F; Haverkamp W; Kelm M; Kuck KH; Landmesser U; Maggioni AP; Metra M; Ninios V; Petrie MC; Rassaf T; Ruschitzka F; Schäfer U; Schulze PC; Spargias K; Vahanian A; Zamorano JL; Zeiher A; Karakas M; Koehler F; Lainscak M; Öner A; Mezilis N; Theofilogiannakos EK; Ninios I; Chrissoheris M; Kourkoveli P; Papadopoulos K; Smolka G; Wojakowski W; Reczuch K; Pinto FJ; Zmudka K; Kalarus Z; Adamo M; Santiago-Vacas E; Ruf TF; Gross M; Tongers J; Hasenfuß G; Schillinger W; Ponikowski P Eur J Heart Fail; 2024 Jul; 26(7):1608-1615. PubMed ID: 38847420 [TBL] [Abstract][Full Text] [Related]
14. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. Grayburn PA; Sannino A; Packer M JACC Cardiovasc Imaging; 2019 Feb; 12(2):353-362. PubMed ID: 30553663 [TBL] [Abstract][Full Text] [Related]
16. An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation. Gaasch WH; Aurigemma GP; Meyer TE JAMA Cardiol; 2020 Apr; 5(4):476-481. PubMed ID: 32074247 [TBL] [Abstract][Full Text] [Related]
17. Advancements in MitraClip Intervention for Mitral Regurgitation: A Comprehensive Review and Comparative Analysis of Clinical Trials. Shrivastava S; Shrivastava S; Allu SVV; Schmidt P; Mohyeldin M; Qasim A Cureus; 2024 Feb; 16(2):e54805. PubMed ID: 38529422 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous mitral valve repair: the necessity to redefine secondary mitral regurgitation. Halim J; Van den Branden B; Coussement P; Kedhi E; Van der Heyden J Neth Heart J; 2020 May; 28(5):272-279. PubMed ID: 32207082 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter treatment of functional mitral regurgitation after MITRA-FR and COAPT - Patient selection is most important. Orban M; Hausleiter J Int J Cardiol; 2019 Aug; 288():57-58. PubMed ID: 30503191 [No Abstract] [Full Text] [Related]
20. Secondary mitral regurgitation: pathophysiology, proportionality and prognosis. Chehab O; Roberts-Thomson R; Ng Yin Ling C; Marber M; Prendergast BD; Rajani R; Redwood SR Heart; 2020 May; 106(10):716-723. PubMed ID: 32054671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]